$238 Million is the total value of Iguana Healthcare Management, LLC's 62 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ESPR | ESPERION THERAPEUTICS INC NE | $18,520,000 | +129.0% | 200,000 | 0.0% | 7.79% | +99.3% | |
CELG | CELGENE CORP | $12,681,000 | +3.1% | 110,000 | 0.0% | 5.33% | -10.3% | |
SUPN | SUPERNUS PHARMACEUTICALS INC | $6,045,000 | +45.7% | 500,000 | 0.0% | 2.54% | +26.8% | |
HZNP | HORIZON PHARMA PLC | $5,194,000 | +101.5% | 200,000 | 0.0% | 2.18% | +75.4% | |
TRNX | TORNIER N V | $3,933,000 | +2.8% | 150,000 | 0.0% | 1.65% | -10.5% | |
CLDX | CELLDEX THERAPEUTICS INC NEW | $2,787,000 | +52.7% | 100,000 | 0.0% | 1.17% | +32.9% | |
SPNC | SPECTRANETICS CORP | $1,738,000 | +0.5% | 50,000 | 0.0% | 0.73% | -12.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2015-06-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOGEN INC | 17 | Q1 2018 | 7.5% |
ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
CELGENE CORP | 15 | Q4 2017 | 7.9% |
AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
DERMIRA INC | 14 | Q1 2018 | 2.7% |
AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2018-05-15 |
13F-HR | 2018-02-14 |
13F-HR/A | 2017-11-16 |
13F-HR | 2017-11-14 |
13F-HR | 2017-08-14 |
13F-HR | 2017-05-15 |
13F-HR | 2017-02-14 |
13F-HR/A | 2016-11-17 |
13F-HR | 2016-11-14 |
13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.